The Point32Health and Freespira partnership
Freespira’s solution has delivered impressive outcomes for Point32Health's members and their bottom-line.
Key takeaways from this study:
- Cost Containment and Financial Risk Mitigation: Freespira has published impressive health economics outcome data, demonstrating cost savings of 35% in a commercial health plan population and a proven return on investment (ROI) in year 1. Freespira also offered performance guarantees, reducing financial risk for Point32Health.
- Member Satisfaction: High Net Promoter Score (NPS): Measures member loyalty and satisfaction. Impressive Customer Satisfaction Score (CSAT): Reflects how satisfied members are with the treatment.
- Insightful Performance Metrics: Quarterly business reviews provide valuable insights into engagement outcomes, clinical outcomes, cost savings, marketing effectiveness, and patient satisfaction.
- Consistently High Enrollment Success: Higher than anticipated enrollment showcased the large need which was supported through rapid engagement and adoption.
- Consistently High Adherence Rates: A remarkable 74%, driven by exacting member identification, targeted member outreach, and personalized high-tech and high-touch support.
"Freespira has health economic evidence demonstrating the cost-effectiveness and potential cost savings associated with its treatment compared to the standard of care. By highlighting reductions in healthcare utilization such as emergency department visits and medication use, Freespira aligned its value proposition with health plan and payor priorities – continuous quality improvement and healthcare cost containment. Freespira has the ability to improve member access to health care regardless of geographic or economic barriers."